Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEMPHASYS LIMITED. Board/Management Information 2016

Sep 29, 2016

65314_rns_2016-09-29_bd951b2a-0ccd-4442-92ee-e7f0dcf00639.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [222 x 64] intentionally omitted <==

ASX Release

Sydney, Australia Friday 30 September 2016

APPOINTMENT & RETIREMENT OF COMPANY SECRETARY

Memphasys Limited (ASX: MEM) ( Company ) is pleased to announce the appointment of Stephanie Georgiou as Company Secretary.

The appointment follows the resignation of Mark Studd. Stephanie is an experienced Company Secretary ensuring a seamless transition of the role.

The Board would like to take this opportunity to acknowledge the valuable contribution of Mr. Studd and wish him well in his future endeavors.

For further information please contact:

Alison Coutts Executive Chairman +61 2 8415 7300 [email protected]

About Memphasys:

Memphasys Limited ( ASX: MEM ) specialises in biological separations for commercial applications. The Company’s patented membrane processes enable the selection of high value substances or contaminants from the fluid in which they are contained by applying an electrical field (electrophoresis) to a sample of the fluid that is contained between our “restriction” membranes and flows through another membrane for separation.

Contact Details E [email protected] P +612 8415 7300 W memphasys.com F +612 8415 7399 ABN 33 120 047 556

Memphasys Limited 30-32 Richmond Road Homebush West NSW 2140

Postal Address P.O. Box 2202 Homebush West NSW 2140